A Multicentre, Parallel Group Open-label Randomised Controlled Non-Inferiority Phase 3 Trial, of ceftolozane-tazobactam versus meropenem for definitive treatment [...] MERINO-3 (2019-2022)
Experts
Dr
Patrick Harris
NHMRC Emerging Leadership Fellow
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
Associate Professor, Infectious Diseases
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
